US20130193364A1 - Method and materials for separating nucleic acid materials - Google Patents

Method and materials for separating nucleic acid materials Download PDF

Info

Publication number
US20130193364A1
US20130193364A1 US13/827,454 US201313827454A US2013193364A1 US 20130193364 A1 US20130193364 A1 US 20130193364A1 US 201313827454 A US201313827454 A US 201313827454A US 2013193364 A1 US2013193364 A1 US 2013193364A1
Authority
US
United States
Prior art keywords
polyethyleneimine
polymer
nucleic acid
materials
carboxylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/827,454
Inventor
Betty Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US13/827,454 priority Critical patent/US20130193364A1/en
Publication of US20130193364A1 publication Critical patent/US20130193364A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/02Polyamines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0206Polyalkylene(poly)amines
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers

Definitions

  • This invention relates to the separation of nucleic acid materials from various sample materials such as whole blood, serum, plasma, solid tissue, body fluids, tissues, hair, nail material, buccal cells, cultured cells, vaginal swabs, bacteria, fungus, and plant tissue. More specifically, the invention relates to methods and materials which allow for the efficient and rapid separation of nucleic acid materials under mild temperature and pH conditions.
  • nucleic acid materials such as DNA, RNA, oligonucleotides, and the like
  • biological samples and other fluids such as cell lysates, synthetic reaction mixtures, PCR reaction mixtures, and the like.
  • separations can be very important steps in various analytical procedures, synthetic procedures, and research activities. Any such method should be reliable, efficient, easy to implement, and not destructive of the nucleic acid materials.
  • positively charged polymers such as polylysine and polyethyleneimine based materials have been used in gene delivery and various nucleic acid purification processes, since these types of molecules can effectively capture and retain negatively charged nucleic acid materials.
  • the charged polymers are typically immobilized on a solid surface, such as a magnetic particle, polystyrene particles or the like.
  • the charged polymer is then contacted with a sample containing a nucleic acid material typically at a pH of less than 8. This causes the nucleic acid material to bind to the positively charged polymer. Impurities such as proteins and carbohydrates do not bind and can be washed away from the sample.
  • the bound nucleic acid material is then released from the polymer under high pH conditions so as to achieve purification.
  • nucleic acid materials bind very strongly to the polymer thereby requiring use of high pH and high temperature conditions to release the bound nucleic acid from the polymer.
  • the nucleic acid materials can be permanently denatured by such high temperature and alkaline reaction conditions. Therefore, there is a need for methods and materials which allow for the separation and purification of nucleic acid materials under relatively mild pH and temperature conditions.
  • the present invention allows for the binding, separation, and release of nucleic acid materials at room temperature and under mildly alkaline conditions.
  • the sample, having the nucleic acid material therein is, in the instance where it includes intact cells first lysed with lysis buffer to release nucleic acid material; in samples which do not include intact cells, this step may be omitted.
  • the fluid is contacted with a positively charged polymer, such as polylysine, polyethyleneimine, or other such polyamines used either singly or in combination.
  • a positively charged polymer such as polylysine, polyethyleneimine, or other such polyamines used either singly or in combination.
  • the unbound impurities are washed away with a washing buffer.
  • the positively charged polymer binds the nucleic acid material thereto; and in a second step of the invention, the polymer having the nucleic acid material bonded thereto is contacted with a releasing agent which comprises a solution of an alkaline material and a glycol.
  • the solution has a pH of no more than 12, and the solution is effective to cause the nucleic acid material to be released from the polymer.
  • the releasing solution may further include a buffer, and in particular instances, the solution has a pH of no more than 11.
  • the alkaline material may comprise a group I metal hydroxide such as sodium hydroxide or potassium hydroxide, and the concentration of the alkaline material may be, in some instances, no more than 50 mM.
  • the glycol in some instances, is a polymeric glycol such as polyethylene glycol, and may have a molecular weight in the range of 200-2000.
  • the step of contacting the polymer with a releasing agent is, in particular instances, carried out at temperatures of no more than 40° C.
  • the positively charged polymer is a carboxylated polyamine.
  • the positively charged polymer may comprise all or a portion of a matrix configured as beads, sheets, slides, tubes, pipettes, swabs, magnetic particles, and the like.
  • the method of the present invention may be implemented in an automated system or on a manual basis.
  • a method for preparing a partially positively charged polyethyleneimine polymer According to the method, a polyethyleneimine polymer is reacted with an acidifying agent, such as a carboxylating agent or a sulfonating agent, so as to produce an acidified polyethyleneimine and that acidified polyethyleneimine is then reacted with a second volume of a polyethyleneimine so as to couple at least some of the acidified polyethyleneimine to the polyethyleneimine of the second volume.
  • the acidifying agent is a carboxylating agent which may be sodium chloroacetate.
  • nucleic acid materials which have been bound to separation reagents are released therefrom by contacting them with a releasing reagent which includes an alkaline material and a glycol.
  • the releasing solution has a pH of no more than 12, and in some instances no more than 11.
  • This solution is effective to release nucleic acid materials at relatively low temperatures, such as temperatures of no more than 50° C.
  • release of the nucleic acid materials takes place at room temperature, which is generally understood to be a temperature of no more than 40° C.
  • the release is accomplished in no more than 10 minutes, and in particular instances no more than 5 minutes.
  • the alkaline material in the releasing agent is a group I metal hydroxide such as sodium hydroxide, potassium hydroxide, or the like.
  • the glycol material may comprise ethylene glycol; however, in some specific instances, it has been found that polymeric glycol materials such as polyethylene glycol polymers are very effective in the practice of the present invention.
  • the concentration of the alkali material is less than 50 mM and the concentration of the glycol component, on a weight basis, is in the range of 1-40%.
  • the molecular weight of the polyethylene glycol polymers can range from 200 to 2000.
  • compositions of this type generally have a pH of no more than 12, and typically no more than 11, and these compositions have been shown to efficiently release nucleic acid materials from positively charged polymers such as carboxylated polyethyleneimine (PEI) at temperatures of no more than 50° C., and typically no more than 40° C. (room temperature) within 4 or 5 minutes. These mild pH and temperature conditions minimize damage to the nucleic acid materials.
  • the releasing reagent may include further ingredients such as buffers which operate to maintain an appropriate pH level, surfactants, as well as ancillary ingredients such as viscosity control agents and the like.
  • the positively charged polymers used in the present invention may comprise a bulk polymeric material, or they may comprise coatings on substrates such as beads, particles, strips, slides, tubes, or pipettes.
  • the substrates may also comprise bibulous materials such as swabs, sponges, or the like.
  • the positively charged polymeric material may be prepared by derivatizing, grafting, or otherwise modifying a bulk polymeric body.
  • the positively charged polymer is coated onto a magnetic particle, or a magnetically susceptible particle, so as to facilitate collection of the particles by magnetic means.
  • a DNA sample was absorbed onto PEI modified magnetic particles of the type known in the art for use in the separation of nucleic acid materials.
  • the PEI modified magnetic particles were first incubated with a 200 ng sample of purified mouse genomic DNA in 30 microliters of a buffer solution comprising 50 mM Tris-HCl having a pH of 7.5 and further containing 1% of Triton X-100. Incubation was carried out at room temperature for 2 minutes. A series of tubes containing the samples were placed in a magnetic separator and the supernatant was removed carefully with a pipette leaving the particles behind. The bound DNA was released from the particles.
  • the release was carried out utilizing a prior art reagent solution comprising 10 microliters of 20 mM NaOH.
  • the releasing reagent comprised a mixture of 8 mM NaOH and 30% PEG 600, in accord with the present invention.
  • incubation was carried out at room temperature for 4 minutes.
  • the resultant solutions were neutralized with 10 microliters of 100 mM Tris-HCl, pH 8.0.
  • a portion of each sample was then analyzed via agarose gel electrophoresis. The electrophoresis analysis indicated that the 8 mM NaOH/PEG solution of the present invention efficiently liberated the DNA from the PEI polymer at room temperature conditions, while the prior art high pH solution did not.
  • frozen human peripheral blood was first lysed in 75 microliters of a lysis buffer consisting of 50 mM Tris-HCl, pH 7.5 buffer, containing 100 mM KCl, 1% Triton X-100, and 0.5% SDS. Lysis was carried out for 2 minutes at room temperature. PEI modified magnetic particles (10 microliters, 1.6% v/v) were added to lysate to bind the released DNA. The bound DNA was collected by placing the tubes into a magnetic separator for 2 minutes.
  • a lysis buffer consisting of 50 mM Tris-HCl, pH 7.5 buffer, containing 100 mM KCl, 1% Triton X-100, and 0.5% SDS. Lysis was carried out for 2 minutes at room temperature. PEI modified magnetic particles (10 microliters, 1.6% v/v) were added to lysate to bind the released DNA. The bound DNA was collected by placing the tubes into a magnetic separator for 2 minutes.
  • the released DNA was then neutralized with 4 microliters of a 100 mM Tris-HCl, pH 8.0 buffer.
  • a comparison was carried out utilizing a releasing agent comprising a prior art, glycol-free 20 mM NaOH solution.
  • the resultant materials were analyzed by gel electrophoresis, and this experiment demonstrated that the solution of the present invention was highly effective in releasing the bound DNA, while the prior art solution was not.
  • a sample tube containing the mixture was placed on a magnetic rack so as to form a pellet of the magnetic beads.
  • the supernatant liquid was discarded and the beads were washed once with 400 microliters of a washing buffer (2 mM Na citrate, pH 6.0) and then incubated with 100 microliters of DNase I solution (40 mM Tris, pH 7.5, 8 mM MgCl 2 , 5 mM DTT and 50 units of DNase I) at 37° C. for 15 minutes.
  • the beads were then washed twice with the washing buffer after the DNase I treatment.
  • the bound RNA was then released from the beads with 60 microliters of a release buffer comprising 0.1 M Bis-Tris, pH 9.5 and 30% PEG 600.
  • RNA 10 microliters of the released RNA was used for cDNA synthesis with M-MLV reverse transcriptase obtained from Takara Bio Inc. 2 microliters of the synthesized cDNA from the 50 microliter reaction were used for PCR with primers for human beta-actin cDNA.
  • the cDNA thus prepared was analyzed by gel electrophoresis in comparison with a control sample. The analysis confirmed that the releasing agent of the present invention was highly effective in freeing the RNA from the magnetic particles.
  • a novel, positively charged PEI material was prepared in accord with another aspect of the present invention.
  • a sodium chloroacetate carboxylating agent was used to carboxylate a sample of PEI material (MW 200,000). This process was carried out by a method described by Miroslav Macka et al. “New isoelectric buffers for capillary electrophoresis: N-carboxymethylated polyethyleneimine as a macromolecular isoelectric buffer,” Analyst, 2001, 126, 421-425.
  • this method amy be used to prepare other types of positively charged (acidified) polymers.
  • the PEI could be reacted with a sulfonating reagent so as to produce a sulfonated PEI, which is then coupled with a volume of unsulfonated PEI.
  • the thus-prepared carboxylated PEI magnetic particles were utilized to capture DNA.
  • the binding capacity of various carboxylated PEI magnetic particles were tested with 200-500 nanograms of purified mouse genomic DNA, in a process generally similar to that described with reference to Example 1.
  • supernatants were collected after incubation of the DNA with the carboxylated PEI magnetic particles in 30 microliters of a buffer containing 50 mM Tris-HCl, pH 7.5 and 1% Triton X-100, under room temperature conditions for 2 minutes.
  • the bound DNA was released utilizing a reagent in accord with the present invention comprising 8 mM NaOH and 30% PEG 600, under room temperature conditions.
  • RNA was separated utilizing the carboxylated PEI polymer.
  • RNA was extracted from Cos7 cells. And 500 nanograms of the extracted RNA was then incubated with the carboxylated PEI magnetic particles at room temperature for 2 minutes. The bound RNA was then released utilizing, in one instance, a Bis-Tris pH 9.0 buffer, and in another instance the same Bis-Tris buffer with polyethylene glycol. The releasing was carried out 42° C. for 3 minutes. The thus-released RNA was subject to quantitative SYBR green PCR with primers specifically to monkey cyclophilin A. It was found that the addition of the PEG to the buffer improves RNA recovery significantly.
  • the releasing agents of the present invention may be prepared utilizing alkali materials other than the described sodium hydroxide.
  • other glycol materials including polymeric and oligomeric glycols, as well as monomeric glycols, may be used in the practice of the present invention.
  • the present invention may be implemented in automated as well as manual modes.
  • kits for carrying out the method may be prepared. All of such modifications and variations are within the scope of the present invention. It is the following claims, including all equivalents, which define the invention.

Abstract

Nucleic acid material can be effectively separated from a fluid under mild conditions by the use of a positively charged polymer which binds the nucleic acid material. Disclosed is a novel positively charged polymer which may be employed in the separation process. This polymer comprises an acidified polyamine, such as polyethyleneimine which has been reacted with a nonacidified polyethyleneimine in a coupling reaction. The acidified polyethyleneimine may be a coarboxylated and/or sulfonated polyethyleneimine.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a divisional of U.S. patent application Ser. No. 12/966,056 filed Dec. 13, 2010, which claims priority of U.S. Provisional Patent Application Ser. No. 61/286,082 filed Dec. 14, 2009, and entitled “Method and Materials for Separating Nucleic Acid Materials”, the disclosure of which is incorporated herein by reference.
  • FIELD OF THE INVENTION
  • This invention relates to the separation of nucleic acid materials from various sample materials such as whole blood, serum, plasma, solid tissue, body fluids, tissues, hair, nail material, buccal cells, cultured cells, vaginal swabs, bacteria, fungus, and plant tissue. More specifically, the invention relates to methods and materials which allow for the efficient and rapid separation of nucleic acid materials under mild temperature and pH conditions.
  • BACKGROUND OF THE INVENTION
  • It is often necessary to separate synthetic and naturally occurring nucleic acid materials such as DNA, RNA, oligonucleotides, and the like from various biological samples and other fluids such as cell lysates, synthetic reaction mixtures, PCR reaction mixtures, and the like. Such separations can be very important steps in various analytical procedures, synthetic procedures, and research activities. Any such method should be reliable, efficient, easy to implement, and not destructive of the nucleic acid materials.
  • In many instances, positively charged polymers such as polylysine and polyethyleneimine based materials have been used in gene delivery and various nucleic acid purification processes, since these types of molecules can effectively capture and retain negatively charged nucleic acid materials. In such processes, the charged polymers are typically immobilized on a solid surface, such as a magnetic particle, polystyrene particles or the like. The charged polymer is then contacted with a sample containing a nucleic acid material typically at a pH of less than 8. This causes the nucleic acid material to bind to the positively charged polymer. Impurities such as proteins and carbohydrates do not bind and can be washed away from the sample. The bound nucleic acid material is then released from the polymer under high pH conditions so as to achieve purification. However, in many instances the nucleic acid materials bind very strongly to the polymer thereby requiring use of high pH and high temperature conditions to release the bound nucleic acid from the polymer. However, the nucleic acid materials can be permanently denatured by such high temperature and alkaline reaction conditions. Therefore, there is a need for methods and materials which allow for the separation and purification of nucleic acid materials under relatively mild pH and temperature conditions. As will be explained in detail hereinbelow, the present invention allows for the binding, separation, and release of nucleic acid materials at room temperature and under mildly alkaline conditions. These and other advantages of the invention will be apparent from the discussion and description which follow.
  • BRIEF DESCRIPTION OF THE INVENTION
  • Disclosed is a method for separating nucleic acid material from biological samples or other fluid mixtures. According to the method, the sample, having the nucleic acid material therein is, in the instance where it includes intact cells first lysed with lysis buffer to release nucleic acid material; in samples which do not include intact cells, this step may be omitted. Subsequently, the fluid is contacted with a positively charged polymer, such as polylysine, polyethyleneimine, or other such polyamines used either singly or in combination. The unbound impurities are washed away with a washing buffer. The positively charged polymer binds the nucleic acid material thereto; and in a second step of the invention, the polymer having the nucleic acid material bonded thereto is contacted with a releasing agent which comprises a solution of an alkaline material and a glycol. The solution has a pH of no more than 12, and the solution is effective to cause the nucleic acid material to be released from the polymer. The releasing solution may further include a buffer, and in particular instances, the solution has a pH of no more than 11. The alkaline material may comprise a group I metal hydroxide such as sodium hydroxide or potassium hydroxide, and the concentration of the alkaline material may be, in some instances, no more than 50 mM.
  • The glycol, in some instances, is a polymeric glycol such as polyethylene glycol, and may have a molecular weight in the range of 200-2000. The step of contacting the polymer with a releasing agent is, in particular instances, carried out at temperatures of no more than 40° C.
  • In some instances, the positively charged polymer is a carboxylated polyamine. The positively charged polymer may comprise all or a portion of a matrix configured as beads, sheets, slides, tubes, pipettes, swabs, magnetic particles, and the like. The method of the present invention may be implemented in an automated system or on a manual basis.
  • Further disclosed is a method for preparing a partially positively charged polyethyleneimine polymer. According to the method, a polyethyleneimine polymer is reacted with an acidifying agent, such as a carboxylating agent or a sulfonating agent, so as to produce an acidified polyethyleneimine and that acidified polyethyleneimine is then reacted with a second volume of a polyethyleneimine so as to couple at least some of the acidified polyethyleneimine to the polyethyleneimine of the second volume. In particular instances, the acidifying agent is a carboxylating agent which may be sodium chloroacetate.
  • Further disclosed is a system for carrying out the method of the present invention as well as a kit of parts for carrying out the method of the invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • According to the present invention, nucleic acid materials which have been bound to separation reagents such as positively charged polymers are released therefrom by contacting them with a releasing reagent which includes an alkaline material and a glycol. The releasing solution has a pH of no more than 12, and in some instances no more than 11. This solution is effective to release nucleic acid materials at relatively low temperatures, such as temperatures of no more than 50° C. In particular instances, release of the nucleic acid materials takes place at room temperature, which is generally understood to be a temperature of no more than 40° C. Typically, the release is accomplished in no more than 10 minutes, and in particular instances no more than 5 minutes. These mild conditions avoid, or greatly minimize, damage to the nucleic acid materials.
  • In specific instances, the alkaline material in the releasing agent is a group I metal hydroxide such as sodium hydroxide, potassium hydroxide, or the like. The glycol material may comprise ethylene glycol; however, in some specific instances, it has been found that polymeric glycol materials such as polyethylene glycol polymers are very effective in the practice of the present invention. In specific instances, the concentration of the alkali material is less than 50 mM and the concentration of the glycol component, on a weight basis, is in the range of 1-40%. In particular instances, the molecular weight of the polyethylene glycol polymers can range from 200 to 2000.
  • One specific reagent having utility in the practice of the present invention comprises an approximately 8 mM aqueous solution of sodium hydroxide containing approximately 30% by weight of polyethylene glycol (PEG 600). Other similar compositions will be readily apparent to those of skill in the art. It has been found that compositions of this type generally have a pH of no more than 12, and typically no more than 11, and these compositions have been shown to efficiently release nucleic acid materials from positively charged polymers such as carboxylated polyethyleneimine (PEI) at temperatures of no more than 50° C., and typically no more than 40° C. (room temperature) within 4 or 5 minutes. These mild pH and temperature conditions minimize damage to the nucleic acid materials. It is to be understood that the releasing reagent may include further ingredients such as buffers which operate to maintain an appropriate pH level, surfactants, as well as ancillary ingredients such as viscosity control agents and the like.
  • The positively charged polymers used in the present invention may comprise a bulk polymeric material, or they may comprise coatings on substrates such as beads, particles, strips, slides, tubes, or pipettes. The substrates may also comprise bibulous materials such as swabs, sponges, or the like. In some instances, the positively charged polymeric material may be prepared by derivatizing, grafting, or otherwise modifying a bulk polymeric body. In some cases, the positively charged polymer is coated onto a magnetic particle, or a magnetically susceptible particle, so as to facilitate collection of the particles by magnetic means.
  • A series of experiments illustrating the principles of the present invention were carried out. In a first experiment, a DNA sample was absorbed onto PEI modified magnetic particles of the type known in the art for use in the separation of nucleic acid materials. In this regard, the PEI modified magnetic particles were first incubated with a 200 ng sample of purified mouse genomic DNA in 30 microliters of a buffer solution comprising 50 mM Tris-HCl having a pH of 7.5 and further containing 1% of Triton X-100. Incubation was carried out at room temperature for 2 minutes. A series of tubes containing the samples were placed in a magnetic separator and the supernatant was removed carefully with a pipette leaving the particles behind. The bound DNA was released from the particles. In a first instance the release was carried out utilizing a prior art reagent solution comprising 10 microliters of 20 mM NaOH. In a second instance, the releasing reagent comprised a mixture of 8 mM NaOH and 30% PEG 600, in accord with the present invention. In either instance, incubation was carried out at room temperature for 4 minutes. The resultant solutions were neutralized with 10 microliters of 100 mM Tris-HCl, pH 8.0. A portion of each sample was then analyzed via agarose gel electrophoresis. The electrophoresis analysis indicated that the 8 mM NaOH/PEG solution of the present invention efficiently liberated the DNA from the PEI polymer at room temperature conditions, while the prior art high pH solution did not.
  • In a second experimental series, frozen human peripheral blood was first lysed in 75 microliters of a lysis buffer consisting of 50 mM Tris-HCl, pH 7.5 buffer, containing 100 mM KCl, 1% Triton X-100, and 0.5% SDS. Lysis was carried out for 2 minutes at room temperature. PEI modified magnetic particles (10 microliters, 1.6% v/v) were added to lysate to bind the released DNA. The bound DNA was collected by placing the tubes into a magnetic separator for 2 minutes. Cell debris in the supernatant was removed, and the magnetic particles having the DNA bound thereto were incubated with 200 microliters of a washing buffer containing 20 mM Tris-HCl, pH 8.0, 0.5% SDS and 200 microgram of proteinase K, for 10 minutes at 60° C. The magnetic particles were then washed with the same buffer solution, not including the proteinase K. After, the particles were washed with 200 microliters of a solution containing 10 mM Tris pH 8.0. The DNA was then released in 16 microliters of a releasing solution of the present invention containing 8 mM NaOH and 30% PEG 600 at room temperature for 4 minutes. The released DNA was then neutralized with 4 microliters of a 100 mM Tris-HCl, pH 8.0 buffer. A comparison was carried out utilizing a releasing agent comprising a prior art, glycol-free 20 mM NaOH solution. As in Experiment 1, the resultant materials were analyzed by gel electrophoresis, and this experiment demonstrated that the solution of the present invention was highly effective in releasing the bound DNA, while the prior art solution was not.
  • A further experimental series was carried out demonstrating the effectiveness of the composition of the present invention for releasing bound RNA. In this experiment, approximately 4×106 293 cells were quickly harvested from a 10 centimeter tissue culture plate by centrifugation. The supernatant liquid was discarded, and the cell pellet was stored at −80° C. prior to use. In order to isolate the RNA, 400 microliters of a lysis buffer (25 mM Na citrate, 4 M guanidine isothiocyanate, 5 mM EDTA, 2% TX-100) was added to the frozen cell pellet. After mixing, 20 microliters of PEI magnetic beads were added to the lysis buffer and mixed. A sample tube containing the mixture was placed on a magnetic rack so as to form a pellet of the magnetic beads. The supernatant liquid was discarded and the beads were washed once with 400 microliters of a washing buffer (2 mM Na citrate, pH 6.0) and then incubated with 100 microliters of DNase I solution (40 mM Tris, pH 7.5, 8 mM MgCl2, 5 mM DTT and 50 units of DNase I) at 37° C. for 15 minutes. The beads were then washed twice with the washing buffer after the DNase I treatment. The bound RNA was then released from the beads with 60 microliters of a release buffer comprising 0.1 M Bis-Tris, pH 9.5 and 30% PEG 600. 10 microliters of the released RNA was used for cDNA synthesis with M-MLV reverse transcriptase obtained from Takara Bio Inc. 2 microliters of the synthesized cDNA from the 50 microliter reaction were used for PCR with primers for human beta-actin cDNA. The cDNA thus prepared was analyzed by gel electrophoresis in comparison with a control sample. The analysis confirmed that the releasing agent of the present invention was highly effective in freeing the RNA from the magnetic particles.
  • In a fourth experiment, a novel, positively charged PEI material was prepared in accord with another aspect of the present invention. In a first step of the process, a sodium chloroacetate carboxylating agent was used to carboxylate a sample of PEI material (MW 200,000). This process was carried out by a method described by Miroslav Macka et al. “New isoelectric buffers for capillary electrophoresis: N-carboxymethylated polyethyleneimine as a macromolecular isoelectric buffer,” Analyst, 2001, 126, 421-425. Thereafter, 100 mg of the thus-prepared carboxylated PEI was dissolved in 1 milliliter of ethanol, and various volumes ranging from 10-50 microliters of carboxylated PEI were added to 100 microliters of PEI magnetic particles in 50 mM MES buffer, pH 6.1, containing carbodiimide and N-hydroxysuccinimide. The magnetic particles thus prepared were shaken for 2 hours at room temperature. Thereafter, the samples were placed in a magnetic separator and any uncoupled carboxylated PEI was removed. The magnetic particles thus produced were washed twice with 50 mM MES and stored in 100 microliters of 50 mM MES plus 0.1% Triton X-100. It is to be understood that this method amy be used to prepare other types of positively charged (acidified) polymers. For example, the PEI could be reacted with a sulfonating reagent so as to produce a sulfonated PEI, which is then coupled with a volume of unsulfonated PEI.
  • In a subsequent experiment, the thus-prepared carboxylated PEI magnetic particles were utilized to capture DNA. In this regard, the binding capacity of various carboxylated PEI magnetic particles were tested with 200-500 nanograms of purified mouse genomic DNA, in a process generally similar to that described with reference to Example 1. In this regard, supernatants were collected after incubation of the DNA with the carboxylated PEI magnetic particles in 30 microliters of a buffer containing 50 mM Tris-HCl, pH 7.5 and 1% Triton X-100, under room temperature conditions for 2 minutes. The bound DNA was released utilizing a reagent in accord with the present invention comprising 8 mM NaOH and 30% PEG 600, under room temperature conditions. Both bound and unbound DNA were visualized on a 0.8% agarose gel utilizing ethidium bromide staining. It was found that the carboxylated PEI magnetic particle material left no DNA in the supernatant, demonstrating the effectiveness of this novel carboxylated material as a positively charged polymer for the separation of nucleic acid materials.
  • In a subsequent experiment, various releasing solutions were evaluated for their efficacy in releasing DNA from the carboxylated PEI material of the present invention and from prior art noncarboxylated PEI. It was found that if the polymer was not carboxylated, release was somewhat more difficult. Specifically, it was found that, with regard to the non-carboxylated PEI polymer, a composition of sodium hydroxide and PEG 600 (pH 11-12) was required to give greater than 90% recovery of bound DNA, while milder (lower pH) releasing agents, such as a 100 mM Bis-Tris, pH 9.0 solution, were not as effective. In those instances where the carboxylated PEI polymer was employed, it was found that a releasing agent comprising the 100 mM Bis-Tris, pH 9.0 solution can effectively bring about release of approximately 90% of the DNA at room temperature.
  • In a further experiment, RNA was separated utilizing the carboxylated PEI polymer. In this regard, RNA was extracted from Cos7 cells. And 500 nanograms of the extracted RNA was then incubated with the carboxylated PEI magnetic particles at room temperature for 2 minutes. The bound RNA was then released utilizing, in one instance, a Bis-Tris pH 9.0 buffer, and in another instance the same Bis-Tris buffer with polyethylene glycol. The releasing was carried out 42° C. for 3 minutes. The thus-released RNA was subject to quantitative SYBR green PCR with primers specifically to monkey cyclophilin A. It was found that the addition of the PEG to the buffer improves RNA recovery significantly.
  • The foregoing illustrates some embodiments of the present invention. Other embodiments and modifications thereof will be readily apparent to those of skill in the art in view of the teaching presented herein. For example, the releasing agents of the present invention may be prepared utilizing alkali materials other than the described sodium hydroxide. Likewise, other glycol materials including polymeric and oligomeric glycols, as well as monomeric glycols, may be used in the practice of the present invention. Also, it is to be understood that the present invention may be implemented in automated as well as manual modes. And, in accord with the present invention, kits for carrying out the method may be prepared. All of such modifications and variations are within the scope of the present invention. It is the following claims, including all equivalents, which define the invention.

Claims (7)

1. A method for preparing a partially positively charged polyethyleneimine polymer, said method comprising the steps of:
providing a first volume of a polyethyleneimine polymer;
reacting said first volume of polyethyleneimine polymer with an acidifying agent so as to produce an acidified polyethyleneimine;
providing a second volume of a polyethyleneimine polymer; and
reacting said second volume of polyethyleneimine with said acidified polyethyleneimine so as to couple at least some of said carboxylated polyethyleneimine to said polyethyleneimine of said second volume.
2. The method of claim 1, wherein said acidifying agent is a carboxylating agent or a sulfonating agent.
3. The method of claim 1, wherein said acidifying agent is sodium chloroacetate.
4. The method of claim 1, wherein said first volume of polyethyleneimine and/or said second volume of polyethyleneimine has a molecular weight of approximately 400 to 200,000.
5. A system for separating a nucleic acid material from a fluid, said system comprising:
a positively charged polymer which is operative to bind said nucleic acid material; and
a releasing agent, said releasing agent comprising a solution of an alkaline material and a glycol, said solution having a pH of no more than 12, said agent being operative to cause said nucleic acid material to be released from said polymer.
6. The system of claim 5, wherein said polyethyleneimine derivatized solid matrix material comprises a carboxylated polyethyleneimine polymer.
7. A partially positively charged polyethyleneimine polymer comprising: a carboxylated polyethyleneimine polymer which has been reacted with a noncarboxylated polyethyleneimine polymer so as to couple said carboxylated polyethyleneimine polymer to said non carboxylated polyethyleneimine polymer.
US13/827,454 2009-12-14 2013-03-14 Method and materials for separating nucleic acid materials Abandoned US20130193364A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/827,454 US20130193364A1 (en) 2009-12-14 2013-03-14 Method and materials for separating nucleic acid materials

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28608209P 2009-12-14 2009-12-14
US12/966,056 US8415467B2 (en) 2009-12-14 2010-12-13 Method and materials for separating nucleic acid materials
US13/827,454 US20130193364A1 (en) 2009-12-14 2013-03-14 Method and materials for separating nucleic acid materials

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/966,056 Division US8415467B2 (en) 2009-12-14 2010-12-13 Method and materials for separating nucleic acid materials

Publications (1)

Publication Number Publication Date
US20130193364A1 true US20130193364A1 (en) 2013-08-01

Family

ID=44143665

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/966,056 Active 2031-06-22 US8415467B2 (en) 2009-12-14 2010-12-13 Method and materials for separating nucleic acid materials
US13/827,454 Abandoned US20130193364A1 (en) 2009-12-14 2013-03-14 Method and materials for separating nucleic acid materials

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/966,056 Active 2031-06-22 US8415467B2 (en) 2009-12-14 2010-12-13 Method and materials for separating nucleic acid materials

Country Status (5)

Country Link
US (2) US8415467B2 (en)
EP (1) EP2513335A4 (en)
JP (1) JP2013513400A (en)
CN (1) CN102753705A (en)
WO (1) WO2011081869A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109438699A (en) * 2018-09-26 2019-03-08 上海维凯光电新材料有限公司 A kind of modified polyethyleneimine/nano silver composite material and preparation method thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5899731B2 (en) 2011-09-13 2016-04-06 ソニー株式会社 Nucleic acid purification method, nucleic acid extraction method, and nucleic acid purification kit
WO2015148512A1 (en) * 2014-03-24 2015-10-01 Qt Holdings Corp Shaped articles including hydrogels and methods of manufacture and use thereof
US9790467B2 (en) 2015-09-22 2017-10-17 Qt Holdings Corp Methods and compositions for activation or expansion of T lymphocytes
WO2017114844A1 (en) * 2015-12-28 2017-07-06 Koninklijke Philips N.V. Nucleic acid purification system using a single wash and elution buffer solution
CN108795928A (en) * 2018-07-02 2018-11-13 苏州呼呼健康科技有限公司 A method of for DNA and RNA in separation and Extraction cell
CN114317524A (en) * 2021-12-28 2022-04-12 国家粮食和物资储备局科学研究院 Reagent, kit and extraction method for extracting DNA of grain kernel attaching fungi

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5092992A (en) * 1989-06-07 1992-03-03 J. T. Baker Inc. Polyethyleneimine matrixes for affinity chromatography
US5898071A (en) * 1994-09-20 1999-04-27 Whitehead Institute For Biomedical Research DNA purification and isolation using magnetic particles

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622822A (en) * 1994-09-13 1997-04-22 Johnson & Johnson Clinical Diagnostics, Inc. Methods for capture and selective release of nucleic acids using polyethyleneimine and an anionic phosphate ester surfactant and amplification of same
US6914137B2 (en) * 1997-12-06 2005-07-05 Dna Research Innovations Limited Isolation of nucleic acids
WO1999029703A2 (en) * 1997-12-06 1999-06-17 Dna Research Instruments Limited Isolation of nucleic acids
EP1147226B1 (en) * 1999-01-27 2013-01-23 Folim G. Halaka Materials and methods for the purification of polyelectrolytes
CA2366928C (en) * 1999-02-25 2009-07-14 Pall Corporation Positively charged membrane
DE60033505T2 (en) * 1999-03-26 2007-11-22 Upfront Chromatography A/S, Kopenhagen PARTICLE MATERIAL FOR SPINE CLEANING OF BIOMAKROLEOLS, SUCH AS PLASMID DNA, CHROMOSOME DNA, RNA, VIRAL DNA, BACTERIA AND VIRUSES
US6783962B1 (en) * 1999-03-26 2004-08-31 Upfront Chromatography Particulate material for purification of bio-macromolecules
US6310199B1 (en) * 1999-05-14 2001-10-30 Promega Corporation pH dependent ion exchange matrix and method of use in the isolation of nucleic acids
KR20040108672A (en) * 2002-03-21 2004-12-24 아베시아 바이오테크놀러지, 아이엔씨. Purification methods for oligonucleotides and their analogs
GB0212826D0 (en) * 2002-05-31 2002-07-10 Dna Res Innovations Ltd Materials and methods relating to polyions and substance delivery
GB0229287D0 (en) * 2002-12-16 2003-01-22 Dna Res Innovations Ltd Polyfunctional reagents
KR100647306B1 (en) * 2004-12-23 2006-11-23 삼성전자주식회사 1 Method for isolating a nucleic acid using a material positively charged at the first pH and comprising an amino group and a carboxyl group
US20060234251A1 (en) * 2005-04-19 2006-10-19 Lumigen, Inc. Methods of enhancing isolation of RNA from biological samples
DE102005047736B4 (en) * 2005-09-29 2008-08-14 Aj Innuscreen Gmbh Method and system for isolating nucleic acids from any complex starting materials
DE102005059217B4 (en) * 2005-12-07 2011-03-17 Aj Innuscreen Gmbh Method and test kit for the separation, purification and recovery of long and short chain nucleic acids
EP1882739A1 (en) * 2006-06-30 2008-01-30 Qiagen GmbH Nucleic acid extraction method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5092992A (en) * 1989-06-07 1992-03-03 J. T. Baker Inc. Polyethyleneimine matrixes for affinity chromatography
US5898071A (en) * 1994-09-20 1999-04-27 Whitehead Institute For Biomedical Research DNA purification and isolation using magnetic particles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Kohn et al. Biochemistry (1976), Vol. 15, pages 4629-4637. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109438699A (en) * 2018-09-26 2019-03-08 上海维凯光电新材料有限公司 A kind of modified polyethyleneimine/nano silver composite material and preparation method thereof

Also Published As

Publication number Publication date
US20110144286A1 (en) 2011-06-16
US8415467B2 (en) 2013-04-09
WO2011081869A3 (en) 2011-10-13
CN102753705A (en) 2012-10-24
WO2011081869A2 (en) 2011-07-07
EP2513335A4 (en) 2013-09-11
EP2513335A2 (en) 2012-10-24
JP2013513400A (en) 2013-04-22

Similar Documents

Publication Publication Date Title
US8415467B2 (en) Method and materials for separating nucleic acid materials
US9624252B2 (en) Selective nucleic acid fragment recovery
JP3787354B2 (en) Nucleic acid isolation method
AU751324B2 (en) Solid-phase nucleic acid isolation
JP5576363B2 (en) Method for isolating short-chain nucleic acids
EP3455354B1 (en) Protein-based sample collection matrices and devices
US20070031880A1 (en) Chemical treatment of biological samples for nucleic acid extraction and kits therefor
US20080132694A1 (en) Method For Facilitating an Automated Isolation of a Biopolymer Using Magnetic Particles
WO2002090539A2 (en) Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
AU2001297835A1 (en) Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
AU2010289430B2 (en) Methods and compositions for direct chemical lysis
WO2016075701A2 (en) A method for extraction of dna using naked magnetic nanoparticles
EP2730653A1 (en) Method for lysing a fixed biological sample
US20110060135A1 (en) Selective Purification of Small RNAs from Mixtures
EP2171098B1 (en) Methods for extraction and purification of components of biological samples
US20190085318A1 (en) Solid phase negative enrichment
US20030228600A1 (en) DNA isolation method and kit
JPH11196869A (en) Isolation of liponucleic acid
CN116218953A (en) Method for connecting nucleic acid fragment and adaptor
CN109477099A (en) The method for separating nucleic acid with bivalent cation and being eluted with cation chelating agent

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION